RAJIV KUMAR: Open Payments
NPI 1689681173 · AGOURA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,769 in 204 payments from 20 companies in 2025. Trend: 2023 $4,653 · 2024 $4,746 · 2025 $4,769
Food & beverage: $4,769
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 61 | $1,598 |
| Otsuka America Pharmaceutical, Inc. | 15 | $525 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $312 |
| Noven Therapeutics, LLC | 19 | $255 |
| Tris Pharma Inc | 12 | $243 |
| Vanda Pharmaceuticals Inc. | 13 | $242 |
| Lundbeck LLC | 12 | $225 |
| PFIZER INC. | 24 | $204 |
| Collegium Pharmaceutical, Inc. | 8 | $188 |
| Axsome Therapeutics, Inc. | 3 | $167 |
Products named: VRAYLAR, REXULTI, UBRELVY, CAPLYTA, QULIPTA, Xelstrym, FANAPT, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
